Latest News
Circio reports up to 50-fold gene expression gain in eye for circVec-AAV platform
26 February 2026 - Biotechnology company Circio Holding ASA (OSE:CRNA) on Thursday reported new in vivo data showing that its AAV-circVec 4.0 platform achieved up to 50-fold higher gene expression in the eye versus conventional mRNA-based AAV followi...
Melodia Therapeutics reports award of US patent covering MLD-151
26 February 2026 - Melodia Therapeutics AG, a clinical-stage biotechnology company based in Switzerland, announced on Wednesday that the United States Patent and Trademark Office (USPTO) has granted a key a key patent covering a structurally novel DP...
Argo Biopharmaceutical to present BW-20805 Phase II interim data at AAAAI 2026 Annual Meeting
26 February 2026 - Argo Biopharmaceutical Co Ltd, a China-based, clinical-stage small interfering RNA (siRNA) therapeutics company, announced on Wednesday that it has been selected as a late breaking abstract to present Phase II interim data for BW-2...
FDA accepts sNDA for MR-141 for the treatment of presbyopia
...
Bruker launches CellScape XR to advance clinical spatial proteomics
25 February 2026 - Life science research and diagnostics solutions provider Bruker Corporation (Nasdaq:BRKR) has introduced CellScape XR, a next-generation spatial proteomics platform designed to enhance diagnostic and prognostic assay development, t...